Progressive eye pathology in mucopolysaccharidosis type I mice and effects of enzyme replacement therapy-Reference-Cited by-同舟云学术

Progressive eye pathology in mucopolysaccharidosis type I mice and effects of enzyme replacement therapy

Published:2020-04 Issue:3 Volume:48 Page:334-342
ISSN:1442-6404
Container-title:Clinical & Experimental Ophthalmology
language:en
Short-container-title:Clin Experiment Ophthalmol

Author:

Gonzalez Esteban A.¹²,Visioli Fernanda³,Pasqualim Gabriela¹²,Souza Carolina F. M.⁴,Marinho Diane R.⁵⁶,Giugliani Roberto¹²⁴,Matte Ursula¹²,Baldo Guilherme¹²

Affiliation:

1. Gene Therapy CenterHospital de Clinicas de Porto Alegre Porto Alegre Brazil

2. Postgraduate Program in Genetics and Molecular BiologyUFRGS Porto Alegre Brazil

3. Oral Pathology, School of DentistryHospital de Clinicas de Porto Alegre Porto Alegre Brazil

4. Medical Genetics ServiceHospital de Clinicas de Porto Alegre Porto Alegre Brazil

5. Department of OphthalmologyUFRGS Porto Alegre Brazil

6. Ophthalmology ServiceHospital de Clinicas de Porto Alegre Porto Alegre Brazil

Funder

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Fundo de Incentivo a Pesquisa do Hospital de Clínicas de Porto Alegre

Publisher

Wiley

Subject

Ophthalmology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ceo.13713

Reference38 articles.

1. Mucopolysaccharidoses and the Eye

2. The MPS I registry: Design, methodology, and early findings of a global disease registry for monitoring patients with Mucopolysaccharidosis Type I

3. Mucopolysaccharidosis I, II, and VI: brief review and guidelines for treatment

4. The ocular features of the mucopolysaccharidoses

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Laronidase-loaded liposomes reach the brain and other hard-to-treat organs after noninvasive nasal administration;International Journal of Pharmaceutics;2024-07

2. Successful treatment of corneal hypertrophic scar in Hurler syndrome;Clinical Case Reports;2024-06-24

3. Intravitreal enzyme replacement for inherited retinal diseases;Current Opinion in Ophthalmology;2023-12-26

4. Clinical and pathological characterization of ophthalmic disease in a canine model of mucopolysaccharidosis type I;Journal of Inherited Metabolic Disease;2023-01-16

5. 18‐year follow‐up of enzyme‐replacement therapy in two siblings with attenuated mucopolysaccharidosis I;American Journal of Medical Genetics Part A;2022-11-05